Skip to content

Clinical trials

Phase 2 Anemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia Phase: Phase 2 Clear all

255 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20016
200213
200311
200415
200516
200619
20075
20085
20095
20109
201110
201214
201313
201413
20158
20167
20177
20183
20198
20203
20216
202210
20235
20244
20255
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed156
Terminated43
Unknown status18
Recruiting14
Withdrawn12
Active, not recruiting6
Not yet recruiting6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.29
Amgen14
GlaxoSmithKline11
Affymax8
Akebia Therapeutics8
Kyntra Bio8
Hoffmann-La Roche6
Bayer5
Celgene5
Merck Sharp & Dohme LLC5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia255
Renal Insufficiency, Chronic48
Myelodysplastic Syndromes27
Kidney Failure, Chronic25
Neoplasms21
Anemia, Sickle Cell13
Hematologic Diseases12
Thrombocytopenia12
Primary Myelofibrosis10
Leukemia9

Trials

Showing 26 to 50 of 255. Each trial links to its page on Pharma Observatory.

155 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.